Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Cathepsin B and L inhibitors in Fujisawa's pipeline

July 12, 1996

Multidrug resistance modifiers from Vertex

July 12, 1996

Arizona Board of Regents reports antitumor pentapeptides

July 12, 1996

Protein tyrosine kinase inhibitors from Warner-Lambert

July 12, 1996

GT32-B: a novel antibacterial/antitumor immunosuppresant

July 12, 1996

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Antiinflammatory bone resorption inhibitors from Takeda

July 12, 1996

Bayer discloses matrix metalloproteinase inhibitors

July 12, 1996

COX-2 inhibitors for inflammation and/or pain from Roche

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...